A method of improving the stability of a pharmaceutical composition comprising a propellant component, a drug component comprising at least one beclomethasone compound selected from beclomethasone and beclomethasone dipropionate, and ethanol is described. The method comprises using a propellant component comprising 1,1-difluoroethane (HFA-152a).